GlassScriptPhysician profile
Diahnn Campbell
NPI 1871002436
$4,147.76
in general payments reported to CMS, 2019-2025
24 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.36 · 2021: $313 · 2022: $830 · 2023: $709 · 2024: $1,228 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,894 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,893.65 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,032.36 | 2021-2025 | |
| Daiichi Sankyo INC. | $1,019.29 | 2022-2025 | Injectafer |
| Evofem Biosciences, INC. | $359.16 | 2021-2024 | Phexxi |
| Mayne Pharma Commercial LLC | $265.87 | 2021-2024 | |
| Exeltis, USA INC. | $259.28 | 2024-2025 | Slynd |
| Pfizer INC. | $191.75 | 2022-2025 | |
| Astellas Pharma US INC | $178.93 | 2025 | Veozah |
| Sage Therapeutics, LLC | $147.86 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $114.60 | 2022 | |
| Sumitomo Pharma America, INC. | $105.14 | 2024-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $77.01 | 2024-2025 | |
| Therapeuticsmd, INC. | $60.49 | 2021-2022 | |
| Millicent US INC | $55.34 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Biogen, INC. | $54.47 | 2024-2025 | Zurzuvae |
| Meditrina | $43.84 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $36.94 | 2019-2024 | Vaqta, Gardasil, Gardasil 9 |
| Scynexis, INC. | $25.25 | 2022 | |
| Supernus Pharmaceuticals, INC. | $20.91 | 2025 | Qelbree |
| Exact Sciences Corporation | $19.03 | 2023 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $16.90 | 2023 | Balcoltra |
| Lilly USA, LLC | $16.29 | 2025 | Zepbound, Mounjaro |
| Axonics, INC. | $15.81 | 2024 | Axonics |
| Minerva Surgical, INC | $15.65 | 2024 | |
| Agile Therapeutics, INC. | $15.59 | 2024 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diahnn Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.